Timothy Keutzer insider trades
Open-market stock purchases and sales by Timothy Keutzer, Chief Operating Officer at Spero Therapeutics, Inc, from SEC Form 4 filings since Feb 3, 2020.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Feb 6, 2026 | SPRO Spero Therapeutics, Inc | Sold | $44K |
| Feb 4, 2026 | SPRO Spero Therapeutics, Inc | Sold | $7.8K |
| Feb 3, 2026 | SPRO Spero Therapeutics, Inc | Sold | $51.8K |
| Feb 2, 2026 | SPRO Spero Therapeutics, Inc | Bought (not open market) | — |
| Feb 2, 2026 | SPRO Spero Therapeutics, Inc | Sold | $41.6K |
| Feb 2, 2026 | SPRO Spero Therapeutics, Inc | Bought (not open market) | — |
Companies traded
- SPRO Spero Therapeutics, Inc: 12 sales, last Feb 6, 2026